Literature DB >> 22988867

Cellular effects of LRRK2 mutations.

Mark R Cookson1.   

Abstract

Mutations in LRRK2 (leucine-rich repeat kinase 2) are a relatively common cause of inherited PD (Parkinson's disease), but the mechanism(s) by which mutations lead to disease are poorly understood. In the present paper, I discuss what is known about LRRK2 in cellular models, focusing specifically on assays that have been used to tease apart the effects of LRRK2 mutations on cellular phenotypes. LRRK2 expression has been suggested to cause loss of neuronal viability, although because it also has a strong effect on the length of neurites on these cells, whether this is true toxicity or not is unclear. Also, LRRK2 mutants can promote the redistribution of LRRK2 from diffuse cytosolic staining to more discrete structures, at least at high expression levels achieved in transfection experiments. The relevance of these phenotypes for PD is not yet clear, and a great deal of work is needed to understand them in more depth.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22988867      PMCID: PMC4662252          DOI: 10.1042/BST20120165

Source DB:  PubMed          Journal:  Biochem Soc Trans        ISSN: 0300-5127            Impact factor:   5.407


  49 in total

Review 1.  What genetics tells us about the causes and mechanisms of Parkinson's disease.

Authors:  Olga Corti; Suzanne Lesage; Alexis Brice
Journal:  Physiol Rev       Date:  2011-10       Impact factor: 37.312

Review 2.  Membrane trafficking events that partake in autophagy.

Authors:  Andrea Orsi; Hannah E J Polson; Sharon A Tooze
Journal:  Curr Opin Cell Biol       Date:  2009-12-24       Impact factor: 8.382

3.  Role of autophagy in G2019S-LRRK2-associated neurite shortening in differentiated SH-SY5Y cells.

Authors:  Edward D Plowey; Salvatore J Cherra; Yong-Jian Liu; Charleen T Chu
Journal:  J Neurochem       Date:  2008-01-07       Impact factor: 5.372

4.  Interaction of elongation factor 1-alpha with leucine-rich repeat kinase 2 impairs kinase activity and microtubule bundling in vitro.

Authors:  F Gillardon
Journal:  Neuroscience       Date:  2009-06-25       Impact factor: 3.590

5.  Disease-specific phenotypes in dopamine neurons from human iPS-based models of genetic and sporadic Parkinson's disease.

Authors:  Adriana Sánchez-Danés; Yvonne Richaud-Patin; Iria Carballo-Carbajal; Senda Jiménez-Delgado; Carles Caig; Sergio Mora; Claudia Di Guglielmo; Mario Ezquerra; Bindiben Patel; Albert Giralt; Josep M Canals; Maurizio Memo; Jordi Alberch; José López-Barneo; Miquel Vila; Ana Maria Cuervo; Eduard Tolosa; Antonella Consiglio; Angel Raya
Journal:  EMBO Mol Med       Date:  2012-03-08       Impact factor: 12.137

6.  Inhibitors of leucine-rich repeat kinase-2 protect against models of Parkinson's disease.

Authors:  Byoung Dae Lee; Joo-Ho Shin; Jackalina VanKampen; Leonard Petrucelli; Andrew B West; Han Seok Ko; Yun-Il Lee; Kathleen A Maguire-Zeiss; William J Bowers; Howard J Federoff; Valina L Dawson; Ted M Dawson
Journal:  Nat Med       Date:  2010-08-22       Impact factor: 53.440

7.  LRRK2 protein levels are determined by kinase function and are crucial for kidney and lung homeostasis in mice.

Authors:  Martin C Herzig; Carine Kolly; Elke Persohn; Diethilde Theil; Tatjana Schweizer; Thomas Hafner; Christine Stemmelen; Thomas J Troxler; Peter Schmid; Simone Danner; Christian R Schnell; Matthias Mueller; Bernd Kinzel; Armelle Grevot; Federico Bolognani; Martina Stirn; Rainer R Kuhn; Klemens Kaupmann; P Herman van der Putten; Giorgio Rovelli; Derya R Shimshek
Journal:  Hum Mol Genet       Date:  2011-08-09       Impact factor: 6.150

8.  GTPase activity and neuronal toxicity of Parkinson's disease-associated LRRK2 is regulated by ArfGAP1.

Authors:  Klodjan Stafa; Alzbeta Trancikova; Philip J Webber; Liliane Glauser; Andrew B West; Darren J Moore
Journal:  PLoS Genet       Date:  2012-02-09       Impact factor: 5.917

9.  Loss of leucine-rich repeat kinase 2 causes age-dependent bi-phasic alterations of the autophagy pathway.

Authors:  Youren Tong; Emilie Giaime; Hiroo Yamaguchi; Takaharu Ichimura; Yumin Liu; Huiqing Si; Huaibin Cai; Joseph V Bonventre; Jie Shen
Journal:  Mol Neurodegener       Date:  2012-01-09       Impact factor: 14.195

10.  Leucine-rich repeat kinase 2 regulates autophagy through a calcium-dependent pathway involving NAADP.

Authors:  Patricia Gómez-Suaga; Berta Luzón-Toro; Dev Churamani; Ling Zhang; Duncan Bloor-Young; Sandip Patel; Philip G Woodman; Grant C Churchill; Sabine Hilfiker
Journal:  Hum Mol Genet       Date:  2011-10-19       Impact factor: 6.150

View more
  9 in total

1.  Down-regulation of LRRK2 in control and DAT transfected HEK cells increases manganese-induced oxidative stress and cell toxicity.

Authors:  Jerome A Roth; Michelle Eichhorn
Journal:  Neurotoxicology       Date:  2013-04-27       Impact factor: 4.294

Review 2.  Advances in the genetics of Parkinson disease.

Authors:  Joanne Trinh; Matt Farrer
Journal:  Nat Rev Neurol       Date:  2013-07-16       Impact factor: 42.937

3.  Mitochondrial ROS promotes susceptibility to infection via gasdermin D-mediated necroptosis.

Authors:  Chi G Weindel; Eduardo L Martinez; Xiao Zhao; Cory J Mabry; Samantha L Bell; Krystal J Vail; Aja K Coleman; Jordyn J VanPortfliet; Baoyu Zhao; Allison R Wagner; Sikandar Azam; Haley M Scott; Pingwei Li; A Phillip West; Jason Karpac; Kristin L Patrick; Robert O Watson
Journal:  Cell       Date:  2022-07-30       Impact factor: 66.850

4.  LRRK2 phosphorylates novel tau epitopes and promotes tauopathy.

Authors:  Rachel M Bailey; Jason P Covy; Heather L Melrose; Linda Rousseau; Ruth Watkinson; Joshua Knight; Sarah Miles; Matthew J Farrer; Dennis W Dickson; Benoit I Giasson; Jada Lewis
Journal:  Acta Neuropathol       Date:  2013-10-11       Impact factor: 17.088

5.  Mutations in the Matrin 3 gene cause familial amyotrophic lateral sclerosis.

Authors:  Janel O Johnson; Erik P Pioro; Ashley Boehringer; Ruth Chia; Gabriella Restagno; Mario Sabatelli; Robert Bowser; Adriano Chiò; Bryan J Traynor; Howard Feit; Alan E Renton; Hannah A Pliner; Yevgeniya Abramzon; Giuseppe Marangi; Brett J Winborn; J Raphael Gibbs; Michael A Nalls; Sarah Morgan; Maryam Shoai; John Hardy; Alan Pittman; Richard W Orrell; Andrea Malaspina; Katie C Sidle; Pietro Fratta; Matthew B Harms; Robert H Baloh; Alan Pestronk; Conrad C Weihl; Ekaterina Rogaeva; Lorne Zinman; Vivian E Drory; Giuseppe Borghero; Gabriele Mora; Andrea Calvo; Jeffrey D Rothstein; Carsten Drepper; Michael Sendtner; Andrew B Singleton; J Paul Taylor; Mark R Cookson
Journal:  Nat Neurosci       Date:  2014-03-30       Impact factor: 24.884

6.  Increasing microtubule acetylation rescues axonal transport and locomotor deficits caused by LRRK2 Roc-COR domain mutations.

Authors:  Vinay K Godena; Nicholas Brookes-Hocking; Annekathrin Moller; Gary Shaw; Matthew Oswald; Rosa M Sancho; Christopher C J Miller; Alexander J Whitworth; Kurt J De Vos
Journal:  Nat Commun       Date:  2014-10-15       Impact factor: 14.919

7.  Using KASP technique to screen LRRK2 G2019S mutation in a large Tunisian cohort.

Authors:  Zied Landoulsi; Sawssan Benromdhan; Mouna Ben Djebara; Mariem Damak; Hamza Dallali; Rym Kefi; Sonia Abdelhak; Amina Gargouri-Berrechid; Chokri Mhiri; Riadh Gouider
Journal:  BMC Med Genet       Date:  2017-07-06       Impact factor: 2.103

Review 8.  From Synaptic Dysfunction to Neuroprotective Strategies in Genetic Parkinson's Disease: Lessons From LRRK2.

Authors:  Andrea Mancini; Petra Mazzocchetti; Miriam Sciaccaluga; Alfredo Megaro; Laura Bellingacci; Dayne A Beccano-Kelly; Massimiliano Di Filippo; Alessandro Tozzi; Paolo Calabresi
Journal:  Front Cell Neurosci       Date:  2020-07-28       Impact factor: 5.505

9.  Pathway-specific dysregulation of striatal excitatory synapses by LRRK2 mutations.

Authors:  Chuyu Chen; Giulia Soto; Vasin Dumrongprechachan; Nicholas Bannon; Shuo Kang; Yevgenia Kozorovitskiy; Loukia Parisiadou
Journal:  Elife       Date:  2020-10-02       Impact factor: 8.140

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.